Roche inks $308.6M col­lab­o­ra­tion deal with Lead Phar­ma, fo­cus­ing on im­mune-me­di­at­ed dis­ease

Roche is wad­ing deep­er in­to the field of im­mune-me­di­at­ed dis­ease with a €260 mil­lion ($308.6 mil­lion) col­lab­o­ra­tion deal with Nether­lands …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.